The CAM Model—Q&A with Experts
Dagmar Fischer, Georg Fluegen, Paul Garcia, Nassim Ghaffari‐Tabrizi‐Wizsy, Laura Gribaldo, Ruby Yun‐Ju Huang, Volker Rasche, Doménico Ribatti, Xavier Rousset, Marta Pinto, Jean Viallet, Yan Wang, Regine Schneider‐Stock
Abstract
The chick chorioallantoic membrane (CAM), as an extraembryonic tissue layer generated by the fusion of the chorion with the vascularized allantoic membrane, is easily accessible for manipulation. Indeed, grafting tumor cells on the CAM lets xenografts/ovografts develop in a few days for further investigations. Thus, the CAM model represents an alternative test system that is a simple, fast, and low-cost tool to study tumor growth, drug response, or angiogenesis in vivo. Recently, a new era for the CAM model in immune-oncology-based drug discovery has been opened up. Although there are many advantages offering extraordinary and unique applications in cancer research, it has also disadvantages and limitations. This review will discuss the pros and cons with experts in the field.